Relocating its US HQ to Boston, French pharma Ipsen to add 250 jobs
Boston’s biotech hub has attracted yet another HQ, as French pharma company Ipsen said Thursday it will relocate its US operations from New Jersey to Kendall Square.
The company announced the move on the last day of the BIO International Convention, promising to add 250 new jobs with the expansion of its Boston presence. Ipsen, which has a $11.2 billion market cap, already opened two outposts in the city back in 2015: a commercial/manufacturing site at One Kendall Square and an R&D site at 650 East Kendall St. Now, it’s moving all 150 of its Boston employees into the East Kendall location.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.